Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Coleonol
2. Colforsin
3. N,n-dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1h-naphtho(2,1-b)pyran-6-yl Ester Hcl
4. Nkh 477
5. Nkh-477
6. Nkh477
1. Colforsin
2. 66575-29-9
3. Coleonol
4. Colforsina
5. Colforsine
6. Colforsinum
7. Boforsin
8. Hl 362
9. Coleonolk
10. L 75 1362b
11. Forskolin (gmp)
12. 7beta-acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxylabd-14-en-11-one
13. (3r,4ar,5s,6s,6as,10s,10ar,10bs)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyldodecahydro-1h-benzo[f]chromen-5-yl Acetate
14. Hl-362
15. (3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1h-benzo[f]chromen-5-yl Acetate
16. Chembl52606
17. L-751362b
18. 1f7a44v6ou
19. [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] Acetate
20. Chebi:42471
21. Nsc375489
22. Nsc-357088
23. Nsc-375489
24. (3r,4ar,5s,6s,6as,10s,10ar,10bs)-dodecahydro-5,6,10,10b-tetrahydroxy-3,4a,7,7,10a-pentamethyl-3-vinyl-1h-naphtho(2,1-b)pyran-1-one 5-acetate
25. Ncgc00024996-02
26. L-75-1362b
27. 66428-89-5
28. Dsstox_cid_20484
29. Dsstox_rid_79500
30. Dsstox_gsid_40484
31. 1h-naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3r,4ar,5s,6s,6as,10s,10ar,10bs)-
32. Colforsine [french]
33. Colforsinum [latin]
34. Colforsina [spanish]
35. Forslean
36. Colforsin [usan:inn]
37. Fok
38. Smr000471881
39. Cas-66575-29-9
40. C22h34o7
41. Einecs 266-410-9
42. Nsc 357088
43. Nsc 375489
44. Unii-1f7a44v6ou
45. Ocufors
46. Timsaponin-c
47. Forskolin- Bio-x
48. (-)-forskolin
49. Mfcd00082317
50. Forskolin - 10%
51. Forskolin - 20%
52. Forskolin - 40%
53. Colforsin [inn]
54. Colforsin [mi]
55. Colforsin (usan/inn)
56. Colforsin [usan]
57. Forskolin [vandf]
58. Colforsin [mart.]
59. Forskolin/ Rolipram Mixture
60. Molmap_000021
61. 7-beta-acetoxy-8,13-epoxy-1-alpha,6-beta,9-alpha-trihydroxylabd-14-en-11-one
62. Colforsin [who-dd]
63. Forskolin [usp-rs]
64. Schembl4928
65. 1h-naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-
66. Cid_47936
67. Mls001066384
68. Mls001333255
69. Mls001333256
70. Mls002172462
71. Mls002695942
72. Forskolin, Analytical Standard
73. Forskohlii Root Extract (forslean)(20% Forskohlin)
74. Regid_for_cid_47936
75. Gtpl5190
76. Dtxsid8040484
77. Bcbcmap01_000132
78. Ohcqjhsobutrhg-kgghgjdlsa-
79. Bio1_000443
80. Bio1_000932
81. Bio1_001421
82. Hms2235c17
83. Hms3267i16
84. Hms3412g19
85. Hms3676g19
86. Ex-a5963
87. Zinc3977779
88. Tox21_110940
89. Tox21_302399
90. Bdbm50010261
91. Hy-15371g
92. S2449
93. Akos024456384
94. Tox21_110940_1
95. Am81249
96. Ccg-268774
97. Cs-1454
98. Db02587
99. Lmpr0104030004
100. Smp1_000128
101. Ncgc00024996-03
102. Ncgc00024996-04
103. Ncgc00024996-05
104. Ncgc00024996-06
105. Ncgc00024996-07
106. Ncgc00024996-34
107. Ncgc00177971-03
108. Ncgc00255526-01
109. 1h-naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3r-(3alpha,4abeta,5beta,6beta,6aalpha,10alpha,10abeta,10balpha))-
110. 1h-naphtho(2,1-b)pyran-1-one, Dodecahydro-5-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-6,10,10b-trihydroxy-, (3r-(3-alpha,4a-beta,5-beta,6-beta,6a-alpha,10-alpha,10a-beta,10b-alpha))-
111. 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1h-naphtho(2,1-b)pyran-1-one
112. Ac-33150
113. As-17443
114. Bf164487
115. Hy-15371
116. Xf165210
117. Xf165211
118. Xf165212
119. Cs-0622781
120. F0855
121. M-410
122. C09076
123. D03584
124. Mls-0318096.0001
125. A850885
126. Q412747
127. Sr-01000597378
128. Forskolin (constituent Of Forskohlii) [dsc]
129. Forskolin, For Use In Molecular Biology Applications
130. Q-200888
131. Sr-01000597378-1
132. Brd-k09602097-001-04-5
133. Forskolin, From Coleus Forskohlii, >=98% (hplc), Powder
134. Forskolin, United States Pharmacopeia (usp) Reference Standard
135. Coleonol;7beta-acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxylabd-14-en-11-one
136. (3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-1h-naphtho[2,1-b]pyran-5-yl Acetate
137. [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyl-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] Acetate
138. [3r-(3 139. [3r-(3?,4a?,5?,6?,6a?,10?,10a?,10b?)]-5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1h-naphtho[2,1-b]pyran-1-one 140. [3r-(3a,4ab,5b,6b,6aa,10a,10ab,10ba)]-5-(acetyloxy)-3-e Thenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1h-naphtho[2,1-b]pyran-1-one
Molecular Weight | 410.5 g/mol |
---|---|
Molecular Formula | C22H34O7 |
XLogP3 | 1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 410.23045342 g/mol |
Monoisotopic Mass | 410.23045342 g/mol |
Topological Polar Surface Area | 113 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 747 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?